secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2024-01-22T23:59:59+00:00
Accession:  0001628280-24-001805
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead CMO Javier San Martin departing Feb 1; Bruce Given returns as Chief Medical Scientist
--------------------------------------------------------------------------------

- Dr. Javier San Martin, Chief Medical Officer, leaves Arrowhead effective February 1, 2024.
- Bruce Given, retired former COO and R&D head, appointed Chief Medical Scientist to ensure orderly transition.
- Company thanks San Martin for his contributions as CMO and executive team member.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000162828024001805/0001628280-24-001805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000162828024001805/arwr-20240116.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-001805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer